Drug eluting stent implantation for the treatment of symptomatic myocardial bridging is associated with favorable peri-procedural results and short-term outcomes
Autor: | Raymond D. Magorien, Wade T. Schmidt, Charles A. Bush, Ernest L. Mazzaferri, Amit A. Doshi, Anthony R. Orsini |
---|---|
Rok vydání: | 2007 |
Předmět: |
Heart Defects
Congenital Male Acute coronary syndrome medicine.medical_specialty Time Factors Paclitaxel Coronary Vessel Anomalies medicine.medical_treatment Myocardial Infarction Coronary Angiography Risk Assessment Severity of Illness Index Sudden cardiac death Cohort Studies Drug Delivery Systems Restenosis Internal medicine medicine Humans Myocardial infarction Angioplasty Balloon Coronary Vascular Patency Retrospective Studies Sirolimus business.industry Unstable angina Coronary Stenosis Percutaneous coronary intervention Prognosis medicine.disease Survival Analysis Treatment Outcome Drug-eluting stent Conventional PCI Cardiology Female Stents Cardiology and Cardiovascular Medicine business |
Zdroj: | International Journal of Cardiology. 118:e87-e88 |
ISSN: | 0167-5273 |
DOI: | 10.1016/j.ijcard.2007.01.031 |
Popis: | Myocardial bridging is the most common congenital coronary abnormality, and is frequently found on post-mortem cardiac examination. Although often asymptomatic, clinical presentation can vary from unstable angina to sudden cardiac death. Only isolated cases of using drug eluting stents (DES) for bridging segments have been described. Our objective was to retrospectively analyze a series of patients undergoing percutaneous coronary intervention (PCI) with DES for symptomatic myocardial bridging and follow post-procedure outcomes. Results revealed favorable peri-procedural angiographic and short-term clinical results with DES implantation. Although initial data regarding DES implantation for symptomatic myocardial bridging are promising, long-term follow up, particularly related to in-stent restenosis will be important. |
Databáze: | OpenAIRE |
Externí odkaz: |